Guardant Health, Inc. (GH)
93.35
+1.12
(+1.21%)
USD |
NASDAQ |
Mar 03, 16:00
92.68
-0.67
(-0.72%)
After-Hours: 20:00
Guardant Health Research and Development Expense (Annual) : 364.19M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Illumina, Inc. | 951.00M |
| Quest Diagnostics, Inc. | -- |
| Natera, Inc. | 624.11M |
| GeneDx Holdings Corp. | 70.84M |
| EXACT Sciences Corp. | 522.44M |